Urodilatin

Urodilatin is a natriuretic peptide that is produced in the kidney and secreted into the urine. It is structurally similar to atrial natriuretic peptide (ANP), but has a different function and is produced in a different part of the body. Urodilatin was first identified in the 1980s and has been the subject of much research since then.

Structure and Function

Urodilatin is a 32-amino acid peptide that is derived from the same precursor molecule as ANP. However, while ANP is produced in the atria of the heart, urodilatin is produced in the distal tubule and collecting duct of the kidney. The production of urodilatin is stimulated by an increase in blood volume and blood pressure, and its primary function is to increase the excretion of sodium and water in the urine, thereby helping to regulate blood volume and pressure.

Clinical Significance

Urodilatin has been studied for its potential use in the treatment of various medical conditions, including heart failure, kidney failure, and hypertension. Some studies have suggested that urodilatin may have a protective effect on the kidneys, and it has been proposed as a potential therapeutic agent for preventing acute kidney injury following surgery. However, more research is needed to fully understand the potential benefits and risks of urodilatin therapy.

See Also

• Natriuretic peptide
• Atrial natriuretic peptide
• Heart failure
• Kidney failure
• Hypertension

References

Urodilatin Resources
Latest articles Most recent articles Ongoing trials	Wikipedia